Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Masayuki Futagami
Observed names:
Futagami, Masayuki,
M Futagami,
M. Futagami,
MASAYUKI FUTAGAMI,
Masayuki FUTAGAMI
Institutions:
Hirosaki University,
Tokyo Medical University Ibaraki Medical Center
Observed institutions:
Hirosaki University,
Tokyo Medical University,
Okayama University,
Hokkaido University,
Tokyo Medical University Ibaraki Medical Center,
Shin-yurigaoka General Hospital
show all 6
ORCID:
0000-0002-0766-0330
Observed ORCID:
0000-0002-0766-0330
OpenAlex ID:
A5084599632
Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma
2012
·
Ayse Ayhan
, Tsui-Lien Mao
, et al.
·
International Journal of Gynecological Cancer
·
167
Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography
2000
·
Shigemi Sato
, Yoshihito Yokoyama
, et al.
·
Cancer
·
131
Clofibric acid, a peroxisome proliferator–activated receptor α ligand, inhibits growth of human ovarian cancer
2007
·
Yoshihito Yokoyama
, Bing Xin
, et al.
·
Molecular Cancer Therapeutics
·
86
PDF
The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer
2015
·
Makito Mizunuma
, Yoshihito Yokoyama
, et al.
·
International Journal of Clinical Oncology
·
84
Prognostic Significance of Vascular Endothelial Growth Factor and Its Receptors in Endometrial Carcinoma
2000
·
Yoshihito Yokoyama
, Shigemi Sato
, et al.
·
Gynecologic Oncology
·
62
Inhibitory effect of meloxicam, a selective cyclooxygenase‐2 inhibitor, and ciglitazone, a peroxisome proliferator‐activated receptor gamma ligand, on the growth of human ovarian cancers
2007
·
Bing Xin
, Yoshihito Yokoyama
, et al.
·
Cancer
·
59
Decreased ARID1A expression is correlated with chemoresistance in epithelial ovarian cancer
2014
·
Yoshihito Yokoyama
, Yoko Matsushita
, et al.
·
Journal of Gynecologic Oncology
·
55
PDF
Effects of Melatonin on the Proliferation and cis-Diamminedichloroplatinum (CDDP) Sensitivity of Cultured Human Ovarian Cancer Cells
2001
·
Masayuki Futagami
, Shigemi Sato
, et al.
·
Gynecologic Oncology
·
45
Significance of Multi‐Drug‐Resistant Proteins in Predicting Chemotherapy Response and Prognosis in Epithelial Ovarian Cancer*
1999
·
Yoshihito Yokoyama
, Shigemi Sato
, et al.
·
Journal of obstetrics and gynaecology research
·
45
The Prophylactic Effects of a Traditional Japanese Medicine, Goshajinkigan, on Paclitaxel-Induced Peripheral Neuropathy and its Mechanism of Action
2014
·
Yukiko Matsumura
, Yoshihito Yokoyama
, et al.
·
Molecular Pain
·
42
Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor γ in epithelial ovarian tumours
2004
·
A Sakamoto
, Y Yokoyama
, et al.
·
British Journal of Cancer
·
39
PDF
Efficacy of a methyl ester of 5-aminolevulinic acid in photodynamic therapy for ovarian cancers
2010
·
M. Wakui
, Yoshihito Yokoyama
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
35
Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan
2019
·
Harunobu Matsumoto
, Mototsugu Shimokawa
, et al.
·
Journal of Gynecologic Oncology
·
31
PDF
Decreased expression of carbonyl reductase 1 promotes ovarian cancer growth and proliferation
2014
·
YUKI OSAWA
, YOSHIHITO YOKOYAMA
, et al.
·
International Journal of Oncology
·
27
PDF
Carcinosarcoma of the fallopian tube: Report of four cases and review of literature
2012
·
Yoshihito YOKOYAMA
, Megumi YOKOTA
, et al.
·
Asia-Pacific Journal of Clinical Oncology
·
24
A Case of Uterine Leiomyoma with Intravenous Leiomyomatosis—Histological Investigation of the Pathological Condition—
2010
·
Asami Fukuyama
, Yoshihito Yokoyama
, et al.
·
Pathology & Oncology Research
·
24
Clinical and reproductive outcomes of fertility‑sparing surgery in stage�I epithelial ovarian cancer
2019
·
Takafumi Watanabe
, Shu Soeda
, et al.
·
Molecular and Clinical Oncology
·
21
PDF
Paclitaxel and Carboplatin in Patients With Completely or Optimally Resected Carcinosarcoma of the Uterus
2014
·
Ai Otsuki
, Yoh Watanabe
, et al.
·
International Journal of Gynecological Cancer
·
20
Pharmacokinetic analysis of paclitaxel and carboplatin in a patient with advanced ovarian cancer during hemodialysis--case report.
2006
·
Y Yokoyama
, M Futagami
, et al.
·
PubMed
·
17
Syndrome of inappropriate secretion of anti-diuretic hormone following carboplatin-paclitaxel administration in a patient with recurrent ovarian cancer.
2005
·
Y Yokoyama
, T Shigeto
, et al.
·
PubMed
·
16
Differences in the sensitivity of ovarian cancer to photodynamic therapy and the mechanisms for those differences
2017
·
Yoshihito Yokoyama
, Tatsuhiko Shigeto
, et al.
·
Oncology Letters
·
14
PDF
A Strategy Using Photodynamic Therapy and Clofibric Acid to Treat Peritoneal Dissemination of Ovarian Cancer
2016
·
Yoshihito Yokoyama
, Tatsuhiko Shigeto
, et al.
·
Asian Pacific Journal of Cancer Prevention
·
14
PDF
A Case of Small Cell Carcinoma of the Vagina
2013
·
Ryosuke Tamura
, Yoshihito Yokoyama
, et al.
·
Rare Tumors
·
14
PDF
Multicenter Clinicopathological Study of High-GradeSerous Carcinoma Presenting as Primary Peritoneal Carcinoma
2018
·
Shinichi Komiyama
, Yoshihiro Nishijima
, et al.
·
International Journal of Gynecological Cancer
·
11
Can malignant transformation in mature cystic teratoma be preoperatively predicted?
2012
·
M Futagami
, Y Yokoyama
, et al.
·
PubMed
·
11
Show more works
View as search
Works count:
80
Citation count:
1,288
H-index:
18
I10-index:
28
Year
Topic
Type
